XML 38 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
Description of Business, Contribution and Exchange, and Liquidity - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 23, 2021
Jun. 17, 2021
Jun. 30, 2021
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Subsidiary Or Equity Method Investee [Line Items]                        
Common stock shares issued       48,528,247           48,528,247   46,794,295
Common stock par or stated value per share       $ 0.0001           $ 0.0001   $ 0.0001
Proceeds from issuance of common stock                   $ 13,507 $ 0  
Proceeds from initial public offering, net of underwriting discount                   $ 0 237,750  
Stockholders' equity, reverse stock split   one-for-3.5305               The Company’s board of directors approved a one-for-3.5305 reverse stock split of its issued and outstanding common stock and stock options and a proportional adjustment to the existing conversion ratios for the Company’s preferred stock effective as of June 17, 2021    
Restricted Cash and Cash Equivalents       $ 272,100           $ 272,100    
Retained earnings accumulated deficit       199,754           199,754   $ 122,035
Net loss       (27,318) $ (26,469) $ (23,932) $ (19,837) $ (18,405) $ (12,276) (77,719) (50,518)  
Cash and cash equivalents at carrying value       $ 112,394     $ 367,034     $ 112,394 $ 367,034 $ 346,071
Common Stock                        
Subsidiary Or Equity Method Investee [Line Items]                        
Stock Issued during period, for conversion of convertible securities     31,068,102                  
IPO                        
Subsidiary Or Equity Method Investee [Line Items]                        
Common stock shares issued 1,755,000   11,700,000         11,700,000        
Common stock par or stated value per share       $ 19.00           $ 19.00    
Proceeds from issuance of common stock $ 31,000                      
Proceeds from initial public offering, net of underwriting discount                   $ 203,600    
Underwriting discount and commission $ 2,300                 15,600    
Offering Costs                   $ 3,100